Dev Information Technology Limited has informed the Exchange about Bagging/Receiving of orders/contracts
DEVIT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dev Information Technology (DEVIT) has won orders worth approximately ₹4.4 crore from Alivus Lifesciences, a domestic pharmaceutical/life sciences company. The deal includes a ₹3.60 crore engagement for Microsoft Select Plus perpetual licenses, where DEVIT played an advisory role in selecting the right licensing model, and a direct ₹80 lakh order for enterprise software solutions covering Microsoft, Zoho, Adobe, and TeamViewer products. The contract is fixed-cost, domestic in nature, and expected to be executed over 1-2 years. There is no related-party involvement, and promoter group companies have no interest in Alivus Lifesciences.
This is a modest positive for DEVIT, showcasing its capability in enterprise IT advisory and multi-product software deals. However, the order size is relatively small for an NSE-listed IT firm, so the stock price impact is likely to be limited unless such wins signal a growing pipeline.